Skip to main content
logo
GC Biopharma Corp. (KRX:006280)
South Korea flag South Korea · Delayed Price · Currency is KRW
132,600
-1,200 (-0.90%)
At close: Sep 9, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Manufacturing and Sales of Pharmaceuticals, etc.
1,580.98B
Log In
Log In
Log In
Log In
Upgrade
Manufacturing and Sales of Pharmaceuticals, etc. Growth
9.72%
Log In
Log In
Log In
Log In
Upgrade
Diagnosis and Analysis of Specimens, etc.
200.12B
Log In
Log In
Log In
Log In
Upgrade
Diagnosis and Analysis of Specimens, etc. Growth
-6.38%
Log In
Log In
Log In
Log In
Upgrade
Consolidation Adjustment, etc.
-117.27B
Log In
Log In
Log In
Log In
Upgrade
Consolidation Adjustment, etc. Growth
152.23%
Log In
Log In
Log In
Log In
Upgrade
Other
16.06B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-13.17%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
South Korea
1,416.52B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
1.16%
Log In
Log In
Log In
Log In
Upgrade
Overseas
380.65B
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
39.50%
Log In
Log In
Log In
Log In
Upgrade
Consolidation Adjustment
-117.27B
Log In
Log In
Log In
Log In
Upgrade
Consolidation Adjustment Growth
152.23%
Log In
Log In
Log In
Log In
Upgrade